120 Participants Needed

Brain Stimulation for PTSD

LA
Overseen ByLily A Brown, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania

Trial Summary

What is the purpose of this trial?

This study will be the first of its kind to explore the impact of continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) on arousal symptoms among patients with posttraumatic stress disorder (PTSD). The investigators will demonstrate that IPS cTBS results in significant reduction in arousal (measured by startle response) compared to sham cTBS, that IPS cTBS interacts with extinction training to further improve arousal, and that there is a dose/response effect of cTBS on arousal. The investigators will also demonstrate that IPS cTBS significantly improves retention of extinction learning, the experimental analogue of exposure therapy.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it excludes those who have had recent medication changes in the past 8 weeks. This might mean you need to be stable on your current medications for at least 8 weeks before joining.

What data supports the effectiveness of the treatment Continuous Theta Burst Stimulation for PTSD?

Research suggests that intermittent theta burst stimulation (iTBS), a form of brain stimulation, has shown promise in improving symptoms of PTSD and depression. Studies indicate that iTBS can change brain connectivity patterns, which may help reduce PTSD symptoms.12345

Is theta burst stimulation (TBS) safe for humans?

Theta burst stimulation (TBS) has been studied for various psychiatric conditions and is generally considered safe, with most adverse effects being mild. However, there is a theoretical risk of seizures, so it should be used with caution, and more research is needed to fully understand its long-term safety.12467

How is continuous theta burst stimulation different from other PTSD treatments?

Continuous theta burst stimulation (cTBS) is a unique treatment for PTSD that uses magnetic pulses to stimulate specific brain areas, offering a novel approach compared to traditional therapies like medication or talk therapy. It is a form of transcranial magnetic stimulation (TMS) that is faster and has shown promise in improving symptoms of depression and PTSD, especially in cases where other treatments have not been effective.12489

Research Team

LA

Lily A Brown, PhD

Principal Investigator

University of Pennsylvania

Eligibility Criteria

This trial is for right-handed adults aged 18-60 with PTSD, as diagnosed by the DSM-5 criteria. Participants must not have any metal implants in their body.

Inclusion Criteria

No metal implants
I am between 18 and 60 years old.
Right-handed
See 1 more

Exclusion Criteria

Any medical condition that increases risk for fMRI or cTBS
Claustrophobia
Non-English speaking
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) and undergo extinction training to reduce arousal symptoms

5 weeks
Multiple visits including Days 4, 5, 34, and 35

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessments of startle response and subjective distress

4 weeks

Treatment Details

Interventions

  • Continuous Theta Burst Stimulation
  • Sham Continuous Theta Burst Stimulation
Trial OverviewThe study tests if a brain stimulation technique called Continuous Theta Burst Stimulation (cTBS) to the Intraparietal Sulcus can reduce arousal symptoms in PTSD patients compared to sham (fake) treatment.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Continuous theta burst stimulation to the intraparietal sulcusExperimental Treatment1 Intervention
Continuous theta burst stimulation will be delivered to the individually targeted intraparietal sulcus site at 100% RMT.
Group II: Sham continuous theta burst stimulationPlacebo Group1 Intervention
We will use the coil's electric stimulation functionality that allows for the delivery of a brief electric pulse to the scalp simultaneous to the pulse to mimic actual stimulation.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Findings from Research

Intermittent Theta Burst Stimulation (iTBS) was well-tolerated by eight Australian veterans with PTSD, with only mild to moderate side effects reported, such as cranial pain and headaches, which were manageable with analgesics.
Participants showed significant reductions in PTSD and depression symptoms after 20 sessions of iTBS, along with improvements in cognitive functions like working memory and processing speed, suggesting that iTBS could be a promising new treatment for veterans with PTSD.
Exploring Theta Burst Stimulation for Post-traumatic Stress Disorder in Australian Veterans-A Pilot Study.Nursey, J., Sbisa, A., Knight, H., et al.[2021]
A study involving 50 veterans with PTSD showed that intermittent theta-burst stimulation (iTBS) significantly improved social and occupational functioning after 2 weeks, indicating its potential efficacy as a treatment for PTSD.
One month after treatment, iTBS demonstrated significant reductions in both clinician- and self-rated PTSD symptoms, as well as improvements in depression and functioning, suggesting that iTBS could be a promising new approach for managing PTSD.
Theta-Burst Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder.Philip, NS., Barredo, J., Aiken, E., et al.[2020]
In a randomized, double-blind trial involving 56 patients, intermittent theta burst stimulation (iTBS) over the dorsomedial prefrontal cortex showed a significant reduction in negative symptoms for patients with depression, but not for those with schizophrenia.
The treatment was generally safe and well-tolerated, with serious adverse events occurring only in the sham group, indicating that iTBS may be a promising intervention for depressive symptoms in certain patients.
Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression - a randomized controlled trial.Bodén, R., Bengtsson, J., Thörnblom, E., et al.[2021]

References

Exploring Theta Burst Stimulation for Post-traumatic Stress Disorder in Australian Veterans-A Pilot Study. [2021]
Theta-Burst Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder. [2020]
Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression - a randomized controlled trial. [2021]
Changes in functional connectivity after theta-burst transcranial magnetic stimulation for post-traumatic stress disorder: a machine-learning study. [2022]
Mechanisms and applications of theta-burst rTMS on the human motor cortex. [2009]
Safety and Efficacy of Theta-Burst Stimulation in the Treatment of Psychiatric Disorders: A Review of the Literature. [2019]
Safety of theta burst transcranial magnetic stimulation: a systematic review of the literature. [2022]
A Secondary Analysis on Effects of Theta Burst Transcranial Magnetic Stimulation to Reduce Anger in Veterans With Posttraumatic Stress Disorder. [2022]
Neurochemical effects of theta burst stimulation as assessed by magnetic resonance spectroscopy. [2022]